HO/03/03 10μg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HO/03/03 10μg, covering 2013-04-04 to 2013-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers [Phase 2]